Table 3 The change of glycans in diseases by UPLC
From: Ischemic stroke is associated with the pro-inflammatory potential of N-glycosylated immunoglobulin G
Glycans | CRC | UC | CD | SLE | RA | CKD | PD | HT | T2D | O | DL* | IS |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GP1 | ↑ | – | – | ↑ | ↑ | – | – | – | – | – | – | ↑ |
GP2 | ↑ | – | – | ↑ | ↑ | ↑ | – | – | – | – | ↑ | – |
GP3 | ↑ | – | – | – | – | – | – | – | – | – | – | – |
GP4 | ↑ | ↑ | ↑ | ↑ | – | – | – | ↑ | – | – | ↑ | – |
GP5 | ↑ | – | – | ↑ | – | – | ↓ | – | – | – | ↑ | ↓ |
GP6 | ↑ | ↑ | ↑ | ↑ | – | ↑ | – | ↑ | ↑ | – | ↑ | – |
GP7 | – | – | – | ↑ | – | – | – | – | – | – | – | – |
GP8 | ↓ | – | – | ↓ | – | – | ↑ | – | ↓ | – | – | ↑ |
GP9 | ↓ | ↓ | ↓ | ↓ | – | – | – | – | ↓ | – | – | – |
GP10 | ↓ | – | – | ↑ | – | – | – | – | ↑ | – | – | – |
GP11 | ↓ | – | – | – | – | – | – | – | ↑ | – | ↑ | – |
GP12 | ↓ | – | – | ↑ | – | – | – | ↓ | – | – | – | – |
GP13 | ↓ | – | – | – | – | – | – | ↓ | – | – | – | ↓ |
GP14 | ↓ | ↓ | ↓ | ↓ | – | ↓ | ↑ | ↓ | – | ↓ | ↓ | ↓ |
GP15 | ↓ | – | – | – | – | – | – | ↓ | – | – | – | ↓ |
GP16 | ↑ | – | – | ↓ | – | – | – | – | – | – | – | – |
GP17 | – | – | – | ↑ | – | – | ↓ | – | – | – | – | ↓ |
GP18 | ↓ | ↓ | ↓ | ↓ | – | ↓ | – | ↓ | – | ↓ | ↓ | ↓ |
GP19 | ↓ | – | ↓ | ↑ | – | – | – | – | – | – | – | – |
GP20 | – | – | – | – | – | – | ↓ | – | – | – | ↑ | – |
GP21 | – | – | – | – | – | – | ↓ | – | – | – | ↑ | ↓ |
GP22 | ↓ | – | – | ↑ | ↓ | – | ↓ | – | – | – | – | – |
GP23 | – | – | – | ↓ | – | – | – | – | – | – | – | ↓ |
GP24 | – | – | – | ↑ | ↑ | – | – | – | – | – | – | – |
Galactosylation | ↓ | ↓ | ↓ | ↓ | ↓ | ↓ | ↓ | ↓ | ↓ | ↓ | ↓ | ↓ |
Sialylation | ↓ | – | ↓ | ↓ | – | ↓ | ↓ | ↓ | ↓ | – | ↓ | ↓ |
Fucosylation | ↑ | – | – | ↓ | ↑ | – | – | ↓ | ↓ | – | – | – |
Bisecting GlcNAc | ↓ | – | ↑ | ↑ | – | ↑ | – | ↑ | ↑ | – | ↑ | ↑ |